Locations:
SearchAdvertisement
New reports focus on neuroimaging biomarkers and features of atypical presentations
Perhaps, with caveats: sNfL elevation has low sensitivity and lags MRI activity by at least a month
Early experience with the agents confirms findings from clinical trials
Findings challenge dogma that microglia are exclusively destructive regardless of location in brain
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New review distills insights from studies over the past decade
Updated consensus approach helps clinicians efficiently improve diagnostic accuracy
The disease is not a barrier to pregnancy, but risks from disease-modifying therapies must be managed
In search of optimal imaging biomarkers, best methods for long-term follow-up
Risk of new MS activity is small in those older than 55 with stable disease who stop MS therapy
$1.1M award expands follow-up to six years with focus on clinical endpoints
Advertisement
Advertisement